Related Experiment Videos
T cell repertoire in patients with stable scleroderma
K P Tiev1, J Abriol, M C Burland
1Service de Médecine Interne, Hôpital Saint Antoine, Saint Antoine, Paris, France. kiet.tiev@sat.ap-hop-paris.fr
Clinical and Experimental Immunology
|January 19, 2005
Summary
Established systemic sclerosis (SSc) patients show no significant T cell expansion in skin or blood. This suggests antigen-driven immune responses are less critical in later stages of SSc compared to its onset.
Area of Science:
- Immunology
- Rheumatology
- Autoimmune Diseases
Background:
- T cell oligoclonal expansion in the skin is observed at the onset of systemic sclerosis (SSc).
- The T cell repertoire in later stages of SSc has not been thoroughly evaluated.
- Understanding T cell dynamics is crucial for understanding SSc pathogenesis.
Purpose of the Study:
- To investigate whether a perpetuating immune response contributes to the pathogenesis of stable SSc.
- To analyze the T cell repertoire in patients with diffuse or limited SSc at a later disease stage.
- To compare T cell repertoires in SSc patients with those in primary Raynaud's phenomenon (RP) and healthy controls (Ctrl).
Main Methods:
- Qualitative and quantitative immunoscope analysis of T cell repertoires (total, CD4, CD8) in blood.
- Analysis of 14 T cell receptor beta variable (BV) families.
- T cell repertoire analysis on CD4 T cells after in vitro culture with IL-2 to detect in vivo activated cells.
- Analysis of skin biopsies from SSc patients.
Main Results:
- No detectable clonal T cell expansions were found in the skin of SSc patients, even after IL-2 culture.
- Total T cell, CD4, and CD8 T cell repertoires in the blood of SSc patients showed no significant perturbations compared to RP patients and controls.
- Blood CD4 T cells from SSc patients did not show preferential expansion after IL-2 culture compared to RP and control groups.
Conclusions:
- Antigen-driven immune responses appear to play a diminished role in established SSc compared to the disease onset.
- The findings suggest that mechanisms other than persistent T cell activation may drive the pathology in later stages of SSc.
- Further research is needed to elucidate the role of other immune cells and factors in established SSc.